The biology of ependymomas and emerging novel therapies

AH Saleh, N Samuel, K Juraschka, MH Saleh… - Nature Reviews …, 2022 - nature.com
Ependymomas are rare central nervous system tumours that can arise in the brain's
supratentorial region or posterior fossa, or in the spinal cord. In 1924, Percival Bailey …

Pediatric ependymoma: biological perspectives

JP Kilday, R Rahman, S Dyer, L Ridley, J Lowe… - Molecular Cancer …, 2009 - AACR
The sphingomyelin (SM) cycle is an emerging pathway of signal transduction that plays a
role in the control of cell growth, cell differentiation, and apoptosis. During earlier …

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study

P Castelo-Branco, S Choufani, S Mack… - The lancet …, 2013 - thelancet.com
Background Identification of robust biomarkers of malignancy and methods to establish
disease progression is a major goal in paediatric neuro-oncology. We investigated whether …

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts

DW Ellison, M Kocak, D Figarella-Branger… - Journal of negative …, 2011 - Springer
Background Histopathological grading of ependymoma has been controversial with respect
to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology …

Molecular staging of intracranial ependymoma in children and adults

A Korshunov, H Witt, T Hielscher, A Benner… - Journal of Clinical …, 2010 - ascopubs.org
Purpose The biologic behavior of intracranial ependymoma is unpredictable on the basis of
current staging approaches. We aimed at the identification of recurrent genetic aberrations …

A prognostic gene expression signature in infratentorial ependymoma

K Wani, TS Armstrong, E Vera-Bolanos… - Acta …, 2012 - Springer
Patients with ependymoma exhibit a wide range of clinical outcomes that are currently
unexplained by clinical or histological factors. Little is known regarding molecular …

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival

AE Marinoff, C Ma, D Guo, M Snuderl, KD Wright… - Journal of neuro …, 2017 - Springer
Ependymoma is the third most common brain tumor in children, but there is a paucity of
large studies with more than 10 years of follow-up examining the long-term survival and …

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor …

R Salloum, TR Hummel, SS Kumar, K Dorris… - Journal of neuro …, 2016 - Springer
Telomerase activation is critical in many cancers including central nervous system (CNS)
tumors. Imetelstat is an oligonucleotide that binds to the template region of the RNA …

Childhood brain tumors: epidemiology, current management and future directions

IF Pollack, RI Jakacki - Nature Reviews Neurology, 2011 - nature.com
Brain tumors are the most common solid tumors in children. With the increasingly
widespread availability of MRI, the incidence of childhood brain tumors seemed to rise in the …

Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective …

JP Kilday, B Mitra, C Domerg, J Ward, F Andreiuolo… - Clinical Cancer …, 2012 - AACR
Purpose: The high incidence of recurrence and unpredictable clinical outcome for pediatric
ependymoma reflect the imprecision of current therapeutic staging and need for novel risk …